Considerable advances in the understanding of congenital muscular dyst
rophy made during the past year may allow a new clinical classificatio
n of this disease. In particular, (1) evidence has accumulated to sugg
est that a laminin alpha2-chain (alpha2 subunit of laminin-2 or merosi
n) deficiency causes a type of congenital muscular dystrophy, and (2)
it has been postulated that Fukuyama-type congenital muscular dystroph
y and Walker-Warburg syndrome (but not Finnish muscle-eye-brain diseas
e) are genetically identical diseases.